November 2020: Infectious Disease

Industry News Round-up

As we round out November 2020, we’ve put together more interesting articles related to infectious disease. Learn more about a  successful COVID-detecting AI model, a promising relationship between the MMR vaccine & COVID-19, and a new study behind the causes of fatal influenza.

November 4, 2020 / Mobi Health News

MIT researchers have developed an artificial intelligence tool that listens to a person’s coughing to determine whether or not they may have COVID-19, regardless if they are or are not symptomatic, according to research published last week in IEEE Open Journal of Engineering.

November 20, 2020 / American Society for Microbiology 

The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against COVID-19. In a new study, researchers provide further proof of this by showing that mumps IgG titers, or levels of IgG antibody, are inversely correlated with severity in recovered COVID-19 patients previously vaccinated with the MMR II vaccine.

November 25, 2020 / Karolinska Institutet

It is largely unknown why influenza infections lead to an increased risk of bacterial pneumonia. Researchers have now described important findings leading to so-called superinfections, which claim many lives around the world every year.


Download PharPoint’s infectious disease experience overview

[contact-form-7 id=”9108″]